D. A. Enoch, H. Yang, S. H. Aliyu, and C. Micallef, The changing epidemiology of invasive fungal infections, Meth. Mol. Biol, vol.1508, pp.17-65, 2017.

N. Singh, O. Lortholary, B. D. Alexander, K. L. Gupta, G. T. John et al., An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients, Clin. Infect. Dis, vol.40, pp.1756-1761, 2005.

H. Y. Sun and N. Singh, Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients, Curr. Opin. Infect. Dis, vol.22, pp.394-402, 2009.

N. Singh and J. Perfect, Immune reconstitution syndrome and exacerbation of infections after pregnancy, Clin. Infect. Dis, vol.45, pp.1192-1199, 2007.

M. A. French, Immune reconstitution inflammatory syndrome: A reappraisal, Clin. Infect. Dis, vol.48, pp.101-107, 2009.

L. J. Haddow, R. Colebunders, G. Meintjes, S. D. Lawn, J. H. Elliott et al., Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: Proposed clinical case definitions, Lancet Infect. Dis, vol.10, pp.791-802, 2010.

J. R. Perfect, W. E. Dismukes, F. Dromer, D. L. Goldman, J. R. Graybill et al., Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America, Clin. Infect. Dis, vol.50, pp.291-322, 2010.

J. Beardsley, M. Wolbers, F. M. Kibengo, A. M. Ggayi, A. Kamali et al., Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis, N. Engl. J. Med, vol.374, pp.542-554, 2016.

, J. Fungi, vol.4, pp.139-154, 2018.

T. Legris, M. Massad, R. Purgus, H. Vacher-coponat, S. Ranque et al., Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient, Transplant Infect. Dis, vol.13, pp.303-308, 2010.

N. Singh, C. D. Sifri, F. P. Silveira, R. Miller, K. S. Gregg et al., Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes, Transplantation, vol.99, pp.2132-2141, 2015.

H. Y. Sun, B. D. Alexander, S. Huprikar, G. N. Forrest, D. Bruno et al., Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: Implications for the management of immunosuppression, Clin. Infect. Dis, vol.60, pp.36-44, 2014.

N. Singh, O. Lortholary, B. D. Alexander, K. L. Gupta, G. T. John et al., Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome, Transplantation, vol.80, pp.1131-1133, 2005.

F. Lanternier, M. O. Chandesris, S. Poiree, M. E. Bougnoux, F. Mechai et al., Cellulitis revealing a Cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient, Am. J. Transplant, vol.7, pp.2826-2828, 2007.

J. Rhein, N. C. Bahr, B. M. Morawski, C. Schutz, Y. Zhang et al., Detection of high cerebrospinal fluid levels of (1?3)-?-d-Glucan in cryptococcal meningitis, Open Forum Infect. Dis, 2014.

J. Rhein, N. C. Bahr, A. C. Hemmert, J. L. Cloud, S. Bellamkonda et al., Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda, Diagn. Microbiol. Infect. Dis, vol.84, pp.1-6, 2015.

I. Z. Ecevit, C. J. Clancy, I. M. Schmalfuss, and M. H. Nguyen, The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: A call for better disease recognition and evaluation of adjuncts to antifungal therapy, Clin. Infect. Dis, vol.42, pp.1443-1447, 2006.

L. K. Somerville, A. P. Henderson, S. C. Chen, and J. Kok, Successful treatment of Cryptococcus neoformans immune reconstitution inflammatory syndrome in an immunocompetent host using thalidomide, Med. Mycol. Case Rep, vol.7, pp.12-14, 2015.

S. C. Chen, W. Meyer, and T. C. Sorrell, Cryptococcus gattii infections, Clin. Microbiol. Rev, vol.27, pp.980-1024, 2014.

B. Rammaert, A. Desjardins, and O. Lortholary, New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis, Mycoses, vol.55, pp.74-84, 2012.

V. J. Anttila, A. E. Lamminen, S. Bondestam, O. Korhola, M. Färkkilä et al., Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia, Eur. J. Haematol, vol.56, pp.82-87, 1996.

A. Hot, C. Maunoury, S. Poiree, F. Lanternier, J. P. Viard et al., Diagnostic contribution of positron emission tomography with [ 18 F]fluorodeoxyglucose for invasive fungal infections, Clin. Microbiol. Infect, vol.17, pp.409-417, 2011.

B. Rammaert, S. Candon, C. Maunoury, M. Bougnoux, G. Jouvion et al., Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report, Transplant Infect. Dis, vol.19, 2016.

N. De-castro, E. Mazoyer, R. Porcher, E. Raffoux, F. Suarez et al., Hepatosplenic candidiasis in the era of new antifungal drugs: A study in Paris, Clin. Microbiol. Infect, vol.18, pp.185-187, 2000.

M. Ellis, B. Al-ramadi, R. Bernsen, J. Kristensen, H. Alizadeh et al., Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever, J. Med. Microbiol, vol.58, pp.606-615, 2009.

G. Todeschini, C. Murari, R. Bonesi, G. Pizzolo, G. Verlato et al., Invasive aspergillosis in neutropenic patients: Rapid neutrophil recovery is a risk factor for severe pulmonary complications, Eur. J. Clin. Investig, vol.29, pp.453-457, 1999.

, J. Fungi, vol.4, pp.139-155, 2018.

M. H. Miceli, J. Maertens, K. Buvé, M. Grazziutti, G. Woods et al., Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications, Cancer, vol.110, pp.112-120, 2007.

N. Singh, J. F. Suarez, R. Avery, C. Lass-flörl, C. Geltner et al., Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis, Transplant Immunol, vol.29, pp.109-113, 2013.

J. Jung, H. Hong, S. Lee, S. Choi, Y. S. Kim et al., Immune reconstitution inflammatory syndrome in neutropenic patients with invasive pulmonary aspergillosis, J. Infect, vol.70, pp.1-9, 2015.

S. K. Kiprono and J. E. Masenga, Immune reconstitution inflammatory syndrome: Cutaneous and bone histoplasmosis mimicking leprosy after treatment, J. Clin. Exp. Dermatol, vol.03, pp.1-3, 2012.

R. Kiggundu, H. W. Nabeta, R. Okia, J. Rhein, and R. Lukande, Unmasking histoplasmosis immune reconstitution inflammatory syndrome in a patient recently started on antiretroviral therapy, vol.6, pp.27-33, 2016.

L. Passos, C. Talhari, M. Santos, R. Ribeiro-rodrigues, L. C. Ferreira et al., Histoplasmosisassociated immune reconstitution inflammatory syndrome, An Bras. Dermatol, vol.86, pp.168-172, 2011.

A. Jazwinski, S. Naggie, and J. Perfect, Immune reconstitution syndrome in a patient with disseminated histoplasmosis and steroid taper: Maintaining the perfect balance, Mycoses, vol.54, pp.270-272, 2011.

P. Vergidis, R. K. Avery, L. J. Wheat, J. L. Dotson, M. A. Assi et al., Histoplasmosis complicating tumor necrosis factor-? blocker therapy: A retrospective analysis of 98 cases, Clin. Infect. Dis, vol.61, pp.409-417, 2015.

G. Breton, H. Adle-biassette, A. Therby, J. Ramanoelina, L. Choudat et al., Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis, AIDS, vol.20, pp.119-121, 2006.

J. C. Edman, J. A. Kovacs, H. Masur, D. V. Santi, H. J. Elwood et al., Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi, Nature, vol.334, pp.519-522, 1988.

C. F. Thomas and A. H. Limper, Current insights into the biology and pathogenesis of Pneumocystis pneumonia, Nat. Rev. Micro, vol.5, pp.298-308, 2007.

H. Kim, J. Y. Heo, Y. Lee, S. J. Kim, and H. W. Jeong, Unmasking granulomatous Pneumocystis jirovecii pneumonia with nodular opacity in an HIV-infected patient after initiation of antiretroviral therapy, Yonsei Med. J, vol.57, pp.1042-1045, 2016.

S. M. Barry, M. C. Lipman, A. R. Deery, M. A. Johnson, and G. Janossy, Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects, HIV Med, vol.3, pp.207-211, 2002.

A. K. Wu, V. C. Cheng, B. S. Tang, I. F. Hung, R. A. Lee et al., The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: Case reports and literature review, BMC Infect. Dis, vol.4, pp.543-548, 2004.

H. P. Mok, E. Hart, and P. Venkatesan, Early development of immune reconstitution inflammatory syndrome related to Pneumocystis pneumonia after antiretroviral therapy, Int J STD AIDS, vol.25, pp.373-377, 2014.

M. C. Godoy, C. I. Silva, J. Ellis, P. Phillips, and N. L. Müller, Organizing pneumonia as a manifestation of Pneumocystis jiroveci immune reconstitution syndrome in HIV-positive patients: Report of 2 cases, J. Thorac. Imaging, vol.23, pp.39-43, 2008.

M. Wislez, E. Bergot, M. Antoine, A. Parrot, M. Carette et al., Acute Respiratory Failure Following HAART Introduction in Patients Treated for Pneumocystis carinii Pneumonia, Am. J. Respir. Crit. Care Med, vol.164, pp.847-851, 2001.

A. Alanio, P. M. Hauser, K. Lagrou, W. J. Melchers, J. Helweg-larsen et al., ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients, J. Antimicrob. Chemother, vol.71, pp.2386-2396, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01405217

S. Mori, S. Polatino, and R. M. Estrada-y-martin, Pneumocystis-associated organizing pneumonia as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected individual with a normal CD4+ T-cell count following antiretroviral therapy, Int. J. STD AIDS, vol.20, pp.662-665, 2009.

R. Kleindienst, F. Fend, C. Prior, R. Margreiter, and W. Vogel, Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis carinii infection in a liver transplant patient receiving tacrolimus, Clin. Transplant, vol.13, pp.65-67, 1999.

N. Verma and B. Soans, Cryptogenic organizing pneumonia associated with Pneumocystis carinii infection and sirolimus therapy in a renal transplant patient, Australas. Radiol, vol.50, pp.68-70, 2006.

C. Hall, R. Hajjawi, G. Barlow, H. Thaker, K. Adams et al., Penicillium marneffei presenting as an immune reconstitution inflammatory syndrome (IRIS) in a patient with advanced HIV, BMJ Case Rep, 2013.

T. Sudjaritruk, T. Sirisanthana, and V. Sirisanthana, Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: A case report and review of literature, BMC Infect. Dis, vol.12, pp.28-31, 2012.

L. Saikia, R. Nath, D. Hazarika, and J. Mahanta, Atypical cutaneous lesions of Penicillium marneffei infection as a manifestation of the immune reconstitution inflammatory syndrome after highly active antiretroviral therapy, Indian J. Dermatol. Venereol. Leprol, vol.76, pp.45-48, 2010.

A. Ho, G. S. Shankland, and R. A. Seaton, Penicillium marneffei infection presenting as an immune reconstitution inflammatory syndrome in an HIV patient, Int. J. STD AIDS, vol.21, pp.780-782, 2010.

N. T. Thanh, L. D. Vinh, N. T. Liem, C. Shikuma, J. N. Day et al., Clinical features of three patients with paradoxical immune reconstitution inflammatory syndrome associated with Talaromyces marneffei infection, Med. Mycol. Case Rep, vol.19, pp.33-37, 2018.

R. B. Mortimer, R. Libke, B. Eghbalieh, and J. F. Bilello, Immune reconstitution inflammatory syndrome presenting as superior vena cava syndrome secondary to Coccidioides lymphadenopathy in an HIV-infected patient, J. Int. Assoc. Physicians AIDS Care, vol.7, pp.283-285, 2008.

S. M. Almeida and T. H. Roza, HIV Immune Recovery Inflammatory Syndrome and Central Nervous System Paracoccidioidomycosis, Mycopathologia, vol.182, pp.1-4, 2016.

M. C. Galhardo, M. T. Silva, M. A. Lima, E. P. Nunes, L. E. Schettini et al., Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome, J. Neurol. Neurosurg. Psychiatry, vol.81, pp.696-699, 2010.

A. Dony, T. Perpoint, S. Ducastelle, and T. Ferry, Disseminated fusariosis with immune reconstitution syndrome and cracking mycotic aortic aneurysm in a 55-year-old patient with acute myeloid leukaemia, BMJ Case Rep, 2013.

K. Crombie, Z. Spengane, M. Locketz, S. Dlamini, R. Lehloenya et al., Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy, PLoS Negl. Trop. Dis, vol.12, 2018.

F. Legrand, M. Lecuit, B. Dupont, E. Bellaton, M. Huerre et al., Adjuvant corticosteroid therapy for chronic disseminated candidiasis, Clin. Infect. Dis, vol.46, pp.696-702, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00484231

O. Lortholary, A. Fontanet, N. Mémain, A. Martin, K. Sitbon et al., French Cryptococcosis Study Group. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France, AIDS, vol.19, pp.1043-1049, 2005.

E. Bettelli, T. Korn, M. Oukka, and V. K. Kuchroo, Induction and effector functions of TH17 cells, Nature, vol.453, pp.1051-1057, 2008.

C. T. Weaver and R. D. Hatton, Interplay between the TH17 and TReg cell lineages: A (co-)evolutionary perspective, Nat. Rev. Immunol, vol.9, pp.883-889, 2009.

C. T. Weaver, R. D. Hatton, P. R. Mangan, and L. E. Harrington, IL-17 Family Cytokines and the Expanding Diversity of Effector T Cell Lineages, Ann. Rev. Immunol, vol.25, pp.821-852, 2007.

F. O. Martinez and S. Gordon, The M1 and M2 paradigm of macrophage activation: Time for reassessment, vol.6, pp.13-19, 1000.

G. M. Shearer, HIV-Induced immunopathogenesis, Immunity, vol.9, pp.587-593, 1998.

, J. Fungi, vol.4, pp.139-157, 2018.

Y. Becker, The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers-a review and hypothesis, Virus Genes, vol.28, pp.5-18, 2004.

Y. Zhang, M. He, Y. Wang, and A. Liao, Modulators of the Balance between M1 and M2 Macrophages during Pregnancy, Front. Immunol, vol.8, 2017.

S. Tsiodras, G. Samonis, D. T. Boumpas, and D. P. Kontoyiannis, Fungal Infections Complicating Tumor Necrosis Factor ? Blockade Therapy, Mayo Clin. Proc, vol.83, pp.181-194, 2008.

Y. Yasunami, S. Kojo, H. Kitamura, A. Toyofuku, M. Satoh et al., V?14 NK T cell-triggered IFN-? production by Gr-1 +CD11b +cells mediates early graft loss of syngeneic transplanted islets, J. Exp. Med, vol.202, pp.913-918, 2005.

J. L. Flynn, J. Chan, and P. L. Lin, Macrophages and control of granulomatous inflammation in tuberculosis, Mucosal Immunol, vol.4, pp.271-278, 2011.

P. Das, R. Rampal, S. Udinia, T. Kumar, S. Pilli et al., Selective M1 macrophage polarization in granuloma-positive and granuloma-negative Crohn's disease, in comparison to intestinal tuberculosis, Intest. Res, vol.16, pp.426-435, 2018.

S. Gordon, Alternative activation of macrophages, Nat. Rev. Immunol, vol.3, pp.23-35, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00474829

G. Martin-blondel, L. T. Mars, and R. S. Liblau, Pathogenesis of the immune reconstitution inflammatory syndrome in HIV-infected patients, Curr. Opin. Infect. Dis, vol.25, pp.312-320, 2012.

J. Nilsson, A. Boasso, P. A. Velilla, R. Zhang, M. Vaccari et al., HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS, Blood, vol.108, pp.3808-3817, 2006.

M. Montes, C. Sanchez, D. E. Lewis, E. A. Graviss, C. Seas et al., Normalization of FoxP3+ Regulatory T Cells in Response to Effective Antiretroviral Therapy, J. Infect. Dis, vol.203, pp.496-499, 2010.

N. Seddiki, S. C. Sasson, B. Santner-nanan, M. Munier, D. Van-bockel et al., Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease, Eur. J. Immunol, vol.39, pp.391-403, 2009.

P. R. Ingram, R. Howman, M. F. Leahy, and J. R. Dyer, Cryptococcal Immune Reconstitution Inflammatory Syndrome following Alemtuzumab Therapy, Clin. Infect. Dis, vol.44, pp.115-117, 2007.

M. Otahbachi and K. Nugent, Granulomatous Pneumocystis jiroveci pneumonia in a patient with chronic lymphocytic leukemia: A literature review and hypothesis on pathogenesis, Phytochemistry, vol.333, pp.131-135, 2007.

L. Li, L. Huang, S. J. Sung, P. I. Lobo, M. G. Brown et al., NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury, J. Immunol, vol.178, pp.5899-5911, 2007.

A. Mantovani, M. A. Cassatella, C. Costantini, and S. Jaillon, Neutrophils in the activation and regulation of innate and adaptive immunity, Nat. Rev. Immunol, vol.11, pp.519-531, 2011.

M. Pelletier, L. Maggi, A. Micheletti, E. Lazzeri, N. Tamassia et al., Evidence for a cross-talk between human neutrophils and Th17 cells, Blood, vol.115, pp.335-343, 2010.

I. J. Elenkov, R. L. Wilder, V. K. Bakalov, A. A. Link, M. A. Dimitrov et al., IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: Implications for autoimmune disease activity during these times, J. Clin. Endocrinol. Metab, vol.86, pp.4933-4938, 2001.

S. Bellocchio, R. Gaziano, S. Bozza, G. Rossi, C. Montagnoli et al., Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4, J. Antimicrob. Chemother, vol.55, pp.214-222, 2005.

R. Ben-ami, R. E. Lewis, and D. P. Kontoyiannis, Immunocompromised Hosts: Immunopharmacology of Modern Antifungals, Clin. Infect. Dis, vol.47, pp.226-235, 2008.

C. Gil-lamaignere, E. Roilides, A. Maloukou, I. Georgopoulou, G. Petrikkos et al., Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum, J. Antimicrob. Chemother, vol.50, pp.1027-1030, 2002.

E. Roilides, C. A. Lyman, J. Filioti, O. Akpogheneta, T. Sein et al., Amphotericin B Formulations Exert Additive Antifungal Activity in Combination with Pulmonary Alveolar Macrophages and Polymorphonuclear Leukocytes against Aspergillus fumigatus, Antimicrob. Agents Chemother, vol.46, pp.1974-1976, 2002.

M. Simitsopoulou, E. Roilides, A. Maloukou, C. Gil-lamaignere, and T. J. Walsh, Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes, Mycoses, vol.51, pp.147-154, 2008.

K. Voelz and R. C. May, Cryptococcal Interactions with the Host Immune System, Eukaryotic Cell, vol.9, pp.835-846, 2010.

D. L. Wiesner, O. Moskalenko, J. M. Corcoran, T. Mcdonald, M. A. Rolfes et al., Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis, vol.3, pp.196-208, 2012.

M. Desnos-ollivier, S. Patel, A. R. Spaulding, C. Charlier, D. Garcia-hermoso et al., Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans. mBio, vol.1, pp.1-9, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-02195111

A. Alanio, M. Gits-muselli, S. Mercier-delarue, F. Dromer, and S. Bretagne, Diversity of Pneumocystis jirovecii during infection revealed by ultra-deep pyrosequencing, Front. Microbiol, vol.7, p.733, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01405203

P. Price, G. Morahan, D. Huang, E. Stone, K. Y. Cheong et al., Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases, AIDS, vol.16, pp.2043-2047, 2002.

G. O. Ogola, C. Ouma, W. G. Jura, E. O. Muok, R. Colebunders et al., A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population, BMC Infect. Dis, vol.14, pp.1-7, 2014.

E. H. Choi, C. B. Foster, J. G. Taylor, H. C. Erichsen, R. A. Chen et al., Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes, J. Infect. Dis, vol.187, pp.1153-1156, 2003.

G. Narendran, D. Kavitha, R. Karunaianantham, L. Gil-santana, J. L. Almeida-junior et al., Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV, PLoS ONE, vol.11, 2016.

G. Meintjes, J. Scriven, and S. Marais, Management of the Immune Reconstitution Inflammatory Syndrome, Curr HIV/AIDS Rep, vol.2012, pp.238-250

T. Rhen and J. A. Cidlowski, Anti-inflammatory action of glucocorticoids-New mechanisms for old drugs, N. Engl. J. Med, vol.353, pp.1711-1723, 2005.

P. Nahid, S. E. Dorman, N. Alipanah, P. M. Barry, J. L. Brozek et al., Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, vol.63, pp.147-195, 2016.

G. Meintjes, R. J. Wilkinson, C. Morroni, D. J. Pepper, K. Rebe et al., Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome, AIDS, vol.24, pp.1-19, 2010.

D. Caillot, J. F. Couaillier, A. Bernard, O. Casasnovas, D. W. Denning et al., Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia, J. Clin. Oncol, vol.19, pp.253-259, 2001.

G. Crespo, C. Cervera, J. Michelena, F. Marco, A. Moreno et al., Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient, Liver Transplant, vol.14, pp.1671-1674, 2008.

, J. Fungi, vol.4, p.22, 2018.

J. S. Montaner, Corticosteroids Prevent Early Deterioration in Patients with Moderately Severe Pneumocystis carinii Pneumonia and the Acquired Immunodeficiency Syndrome (AIDS), Ann. Intern. Med, vol.113, pp.14-20, 1990.

S. Chabria, L. Barakat, and O. Ogbuagu, Steroid-exacerbated HIV-associated cutaneous Kaposi's sarcoma immune reconstitution inflammatory syndrome, Int. J. STD AIDS, vol.27, pp.1026-1029, 2016.

M. Fernández-sánchez, M. C. Iglesias, Y. Ablanedo-terrazas, C. E. Ormsby, . Alvarado-de-la et al., Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection, AIDS, vol.30, pp.909-914, 2016.

T. K. Blackmore, L. Manning, W. J. Taylor, and R. S. Wallis, Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes, Clin. Infect. Dis, vol.47, pp.83-85, 2008.

D. C. Hsu, K. F. Faldetta, L. Pei, V. Sheikh, N. S. Utay et al., A paradoxical treatment for a paradoxical condition: Infliximab use in three cases of mycobacterial IRIS, Clin. Infect. Dis, vol.62, pp.258-261, 2015.

N. Lwin, M. Boyle, and J. S. Davis, Adalimumab for Corticosteroid and Infliximab-Resistant Immune Reconstitution Inflammatory Syndrome in the Setting of TB/HIV Coinfection, Open Forum Infect. Dis, vol.5, p.27, 2018.

G. Gaube, N. De-castro, A. Gueguen, C. Lascoux, A. M. Zagdanski et al., Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitis, Medecine et Maladies Infectieuses, vol.46, pp.154-156, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01405206

A. M. Sitapati, C. L. Kao, E. R. Cachay, H. Masoumi, R. S. Wallis et al., Treatment of HIV-Related Inflammatory Cerebral Cryptococcoma with Adalimumab, Clin. Infect. Dis, vol.50, pp.7-10, 2010.

A. Brunel, J. Reynes, E. Tuaillon, P. Rubbo, O. Lortholary et al., Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS, AIDS, vol.26, pp.2110-2112, 2012.

J. E. Kaplan, C. Benson, K. K. Holmes, J. T. Brooks, A. Pau et al., Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, MMR Recomm. Rep, vol.58, pp.1-207, 2009.

P. W. Bergman and L. Björkhem-bergman, Is there a role for statins in fungal infections?, Expert Rev. Anti-Infect. Ther, vol.11, pp.1391-1400, 2014.

H. Y. Sun and N. Singh, Potential role of statins for the management of immune reconstitution syndrome, vol.76, pp.307-310, 2011.

I. M. Tleyjeh, T. Kashour, F. A. Hakim, V. A. Zimmerman, P. J. Erwin et al., Statins for the prevention and treatment of infections: A systematic review and meta-analysis, Arch. Intern. Med, vol.169, pp.1658-1667, 2009.

M. P. Zorzou, M. Chini, A. Lioni, G. Tsekes, T. Nitsotolis et al., Successful treatment of immune reconstitution inflammatory syndrome-related hemophagocytic syndrome in an HIV patient with primary effusion lymphoma, Hematol. Rep, vol.8, 2016.

Z. Calic, C. Cappelen-smith, S. J. Hodgkinson, A. Mcdougall, R. Cuganesan et al., Treatment of progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab, J. Clin. Neurosci, vol.22, pp.598-600, 2015.

M. Müller, S. Wandel, R. Colebunders, S. Attia, H. Furrer et al., Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: A systematic review and meta-analysis, Lancet Infect. Dis, vol.10, pp.251-261, 2010.

Y. C. Manabe, J. D. Campbell, E. Sydnor, and R. D. Moore, Immune reconstitution inflammatory syndrome: Risk factors and treatment implications, J. Acquir. Immune Defic. Syndr, vol.46, pp.456-462, 2007.

C. C. Chang, A. Lim, S. Omarjee, S. M. Levitz, B. I. Gosnell et al., Cryptococcosis-IRIS is associated with lower Cryptococcus-specific IFN-? responses before antiretroviral therapy but not higher T-cell responses during therapy, J. Infect. Dis, vol.208, pp.898-906, 2013.

C. C. Chang, A. A. Dorasamy, B. I. Gosnell, J. H. Elliott, T. Spelman et al., Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome, AIDS, vol.27, pp.2089-2099, 2013.

H. A. Yoon, A. Nakouzi, C. C. Chang, M. H. Kuniholm, L. J. Carreño et al., Association between plasma antibody responses and risk for Cryptococcus-associated immune reconstitution inflammatory syndrome, J. Infect. Dis, vol.17, pp.873-880, 2018.

D. R. Boulware, D. B. Meya, T. L. Bergemann, D. L. Wiesner, J. Rhein et al., Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: A prospective cohort study, PLoS Med, 2010.

D. R. Boulware, S. C. Bonham, D. B. Meya, D. L. Wiesner, G. S. Park et al., Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome, J. Infect. Dis, vol.202, pp.962-970, 2010.

C. C. Chang, S. Omarjee, A. Lim, T. Spelman, B. I. Gosnell et al., Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome, J. Infect. Dis, vol.208, pp.1604-1612, 2013.

R. J. Wilkinson, N. F. Walker, J. Scriven, and G. Meintjes, Immune reconstitution inflammatory syndrome in HIV-infected patients, vol.7, pp.49-64, 2015.

T. Bicanic, G. Meintjes, K. Rebe, A. Williams, A. Loyse et al., Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: A prospective study, J. Acquir. Immune Defic. Syndr, vol.51, pp.130-134, 2009.

S. A. Shelburne, J. Darcourt, A. C. White, S. B. Greenberg, R. J. Hamill et al., The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy, Clin. Infect. Dis, vol.40, pp.1049-1052, 2005.

M. Vitoria, N. Ford, P. Clayden, A. L. Pozniak, and A. M. Hill, When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries, Curr. Opin. HIV AIDS, vol.12, pp.414-422, 2017.

M. Psichogiou, D. Basoulis, M. Tsikala-vafea, S. Vlachos, C. J. Kapelios et al., Integrase Strand Transfer inhibitors and the emergence of Immune Reconstitution Inflammatory Syndrome (IRIS), vol.15, pp.1-6, 2018.

M. Dutertre, L. Cuzin, E. Demonchy, P. Puglièse, V. Joly et al., Initiation of antiretroviral therapy containing integrase inhibitors increases the risk of IRIS requiring hospitalization, J. Acquir. Immune Defic. Syndr, vol.76, pp.23-26, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01906277

M. Chandesris, C. Kelaidi, F. Méchaï, M. Bougnoux, N. Brousse et al., Granulocyte Colony Stimulating Factor-induced exacerbation of fungus-related Immune Restoration Inflammatory Syndrome: A case of chronic disseminated candidiasis exacerbation, J. Microbiol. Immunol. Infect, vol.43, pp.339-343, 2010.

F. Blanc, T. Sok, D. Laureillard, L. Borand, C. Rekacewicz et al., Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis, N. Engl. J. Med, vol.365, pp.1471-1481, 2011.

M. E. Torok, N. T. Yen, T. T. Chau, N. T. Mai, N. H. Phu et al., Timing of Initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-associated tuberculous meningitis, Clin. Infect. Dis, vol.52, pp.1374-1383, 2011.

A. R. Zolopa, J. Andersen, L. Komarow, I. Sanne, A. Sanchez et al., Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: A multicenter randomized strategy trial, PLoS ONE, vol.4, 2009.

, J. Fungi, vol.4, pp.139-161, 2018.

A. T. Makadzange, C. E. Ndhlovu, K. Takarinda, M. Reid, M. Kurangwa et al., Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa, Clin. Infect. Dis, vol.50, pp.1532-1538, 2010.

G. P. Bisson, M. Molefi, S. Bellamy, R. Thakur, A. Steenhoff et al., Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis, Clin. Infect. Dis, vol.56, pp.1165-1173, 2013.

D. R. Boulware, D. B. Meya, C. Muzoora, M. A. Rolfes, K. Huppler-hullsiek et al., Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis, N. Engl. J. Med, vol.370, pp.2487-2498, 2014.

J. E. Scriven, L. M. Graham, C. Schutz, T. J. Scriba, K. A. Wilkinson et al., The CSF Immune Response in HIV-1-Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy, J. Acquir. Imm. Defic. Syndr, vol.75, pp.299-307, 2017.

. Southern-african-hiv-clinicians and T. Society, Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update, S. Afr. J. HIV Med, vol.14, pp.76-86, 2013.

M. Abassi, D. R. Boulware, and J. Rhein, Cryptococcal Meningitis: Diagnosis and Management Update, Curr. Trop. Med. Rep, vol.2, pp.90-99, 2015.

N. Singh, Hypercalcemia Related to Immune Reconstitution in Organ Transplant Recipients with Granulomatous Opportunistic Infections, Transplantation, vol.82, 2006.